Clopidogrel Resistance and Platelet Reactivity in Women Undergoing Percutaneous Coronary Intervention
Completed
- Conditions
- Acute Coronary SyndromeCoronary Artery Disease
- Registration Number
- NCT01796873
- Lead Sponsor
- University of Arizona
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 36
Inclusion Criteria
Inclusion Criteria:<br><br> - All females age 45 or greater, presenting to University of Arizona Medical Center<br> South Campus or University Campus Cardiology service with a history of ACS<br><br> - Hispanics will be defined via self-reporting as having both parents of Latino<br> descent<br><br> - Currently taking clopidogrel<br><br>Exclusion Criteria:<br><br> - Taking any of the following antiplatelet drugs:<br><br> - Prasugrel (Effient)<br><br> - Ticagrelor (Brilinta)<br><br> - Ticlopidine (Ticlid)
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Platelet Reactivity measured by the VerifyNow P2Y12 Assay
- Secondary Outcome Measures
Name Time Method